Eligibility · BMI

GLP-1 Eligibility &
BMI Calculator

Check if you qualify for GLP-1 medication based on your BMI and health conditions — using the same FDA criteria your doctor uses.

Your BMI result
Your BMI
—
—
GLP-1 Eligibility
—
Results are estimates based on clinical data. Individual results vary. Not medical advice.
Based on your results
Ready to get started?
These programs prescribe your medication and ship to your door within days. No in-person visit required.
Best value
Yucca Health
From $146/mo
Oral option
Strut Health
From $199/mo
Microdose option
bmiMD
From $99/mo
Compare all 7 providers →
Sponsored · Compounded GLP-1 not FDA-approved as finished drug · Prices confirmed at intake
About this calculator

FDA eligibility criteria for GLP-1 medication

The FDA approves Wegovy (semaglutide 2.4mg) and Zepbound (tirzepatide) for adults meeting one of two criteria: a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related health condition. This calculator applies those exact criteria to your inputs.

Qualifying health conditions at BMI 27+ include type 2 diabetes, hypertension (high blood pressure), dyslipidaemia (high cholesterol), obstructive sleep apnea, and established cardiovascular disease. You do not need to have all of these — one qualifying condition is sufficient.

No diabetes required: Approximately 70% of current GLP-1 patients in the US are using it for weight management, not diabetes. You do not need a diabetes diagnosis to qualify for Wegovy or Zepbound.

How to get a GLP-1 prescription online

If you meet the eligibility criteria above, the next step is completing a health questionnaire with a licensed telehealth provider. A physician reviews your information — typically within 24 hours — and issues a prescription if you qualify. Medication is then compounded and shipped to your door within 2 to 5 business days. No in-person visit required.

Frequently asked questions
The FDA approves Wegovy and Zepbound for adults with a BMI of 30 or higher, or a BMI of 27 or higher when accompanied by at least one weight-related health condition. The qualifying conditions at BMI 27 include type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, or cardiovascular disease.
Yes. You do not need diabetes to qualify for GLP-1 medication. Wegovy (semaglutide 2.4mg) and Zepbound (tirzepatide) are both FDA-approved for chronic weight management in non-diabetic adults who meet BMI criteria. Approximately 70% of GLP-1 patients currently on treatment in the US are using it for weight loss rather than diabetes management.
Absolute contraindications include a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnancy or breastfeeding is a contraindication. Severe gastroparesis and a history of pancreatitis may be relative contraindications. Your prescribing physician reviews your complete health history to identify any contraindications during the consultation process.
The fastest path is through a telehealth provider. Complete a health questionnaire online (10 to 15 minutes), a licensed physician reviews within 24 hours, and medication is shipped within 2 to 5 business days. Total time from starting the questionnaire to receiving medication is typically 5 to 8 business days.
You may qualify — GLP-1 from $146/mo Yucca Health · Doctor-prescribed
Get started →
Yucca Health · Doctor-prescribed
Get started →